Safeguarding your company’s research, development and innovation
Every business has considerable assets in the form of Industrial Property, which are often not exploited to their fullest potential. Protecting any new solutions developed by R&D departments has become a key requirement for every company. The tools available include patents to protect new products, machinery, devices and industrial systems or processes at either the national, local, European and international level.
Protection
A patent is a legal instrument that gives its holder exclusive rights to exploit an invention across the jurisdiction of the sovereign state that has granted the patent. This means that, for a period of twenty years from the filing date, patents give their owners a precious market protection preventing anyone else from copying their technology.
Strategy
Filing a patent should be considered one of the steps in a wider IP strategy aimed at increasing your business’s market share, protecting it against competitors, and creating opportunities for strategic partnerships, mergers or acquisitions. A strong patent strategy should always be seamlessly integrated with the company’s overall vision.
Scope
Since patents fall under the jurisdiction of individual nations, it is crucial to carefully choose where to file a patent: priority may be given, for example, to the countries where the main competitors are based, or those where the market for the patented product(s) shows the greatest potential. Often, a patent strategy focusing on certain countries allows businesses to gain significant market shares.
Value
A patent is a true corporate asset that can help companies obtain funding or bank loans, generate revenue through royalty payments from license agreements, and even benefit from significant tax breaks. The possibility of profiting from this particular form of protection often serves as an incentive for companies to intensify their research activity and step up investments.
A patent is a true corporate asset that can help companies obtain funding or bank loans, generate revenue through royalty payments from license agreements, and even benefit from significant tax breaks.
Our consultants are qualified professionals accredited by the Italian Patent and Trademark Office (Ufficio Italiano Brevetti e Marchi), the European Patent Office and the World Intellectual Property Organization
We can assist you with the following operations:
Preparing and filing patent applications in Italy and abroad
Consulting and support for examination, opposition and appeal procedures relative to Italian, European and international patents (PCT).
Managing expirations and forwarding all relative notifications
Searches and opinions relating to the validity and patentability of an invention
State of the art studies and feasibility opinions regarding products or processes
Filing transcription and recording petitions for the transfer or updating of patent ownership
Assistance in devising corporate patent strategies
Preparing transfer contracts and licensing agreements
Consulting on counterfeiting-related matters
Appraisal reports
Discover all our other Patent-related services:
News related to Patents:
Siemens Gamesa obtains U.S. ban against General Electric’s wind turbines
The Massachusetts Federal District Court has banned General Electric (“GE”) from manufacturing and selling its Haliade-X wind turbines, 12 to 14 Megawatts offshore products, in the United States, except for some specific projects for the construction of wind turbines...
The UK Government’s wait-and-see approach to the possibility of an artificial intelligence being recognized as an “inventor”
The UK government recently published the response to a public consultation on the relationship between artificial intelligence (AI) and intellectual property. In particular, the consultation focused on the patent protection of inventions conceived by an artificial...
Moderna bounces on the US government the counterfeiting allegations of its Spikevax
On last February 2022, the American biotech companies Arbutus and Genevant filed a lawsuit against Moderna, claiming that the latter would have illegally exploited their patented technology on lipid nanoparticles (LNP) to produce “Spikevax”, the vaccine against the...